FENC · Insider trading · 13F holders · Congress trades
Fennec Pharmaceuticals Inc. (FENC)
Who is buying and selling FENC: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 7
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $1.4M
- Congress trades, 12 months
- 0
FENC at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 4 FENC insiders filed 5 sales worth $1.4M on SEC Form 4, and no open-market purchases; 4 of the sales were pre-planned under Rule 10b5-1.
- 7 13F filers hold FENC among their 50 largest positions, worth $102.8M combined. The biggest bets by portfolio weight are Rosalind Advisors, Inc. (12.9%), Solas Capital Management, LLC (10.9%) and Lion Point Capital, LP (5.8%). In their latest 13Fs, 1 manager opened a new position and 2 added to one.
- No member of Congress has disclosed a trade in FENC.
- FENC last closed at $10.95 on Oct 29, 2026.
FENC insider trading
Between Aug 1, 2026 and Oct 29, 2026, 4 FENC insiders filed 5 sales worth $1.4M on SEC Form 4, and no open-market purchases; 4 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Brughera Marco Maria | Director | Sale10b5-1 | 15,545 | $10.29 | $160K | SEC |
| Sep 1, 2026 | Raykov Rosty | Former Director | Sale10b5-1 | 10,000 | $12.11 | $121K | SEC |
| Aug 31, 2026 | Sayad Pierre Sargis | Chief Medical Officer | Sale | 12,000 | $12.18 | $146K | SEC |
| Aug 28, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Sale10b5-1 | 75,000 | $11.78 | $884K | SEC |
| Aug 4, 2026 | Raykov Rosty | Former Director | Sale10b5-1 | 10,000 | $9.58 | $96K | SEC |
Who owns FENC? Hedge funds and superinvestors
7 13F filers hold FENC among their 50 largest positions, worth $102.8M combined. The biggest bets by portfolio weight are Rosalind Advisors, Inc. (12.9%), Solas Capital Management, LLC (10.9%) and Lion Point Capital, LP (5.8%). In their latest 13Fs, 1 manager opened a new position and 2 added to one.
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc.Investment manager | 12.9% | $34.3M | 3,188,001 | +9.6% shares | Q2 2026 |
| AIGH Capital Management LLCHedge fund | 2.4% | $26.7M | 2,486,038 | +25.5% shares | Q2 2026 |
| Solas Capital Management, LLCHedge fund | 10.9% | $20.3M | 1,889,366 | -23.9% shares | Q2 2026 |
| AWM Investment Company, Inc.Hedge fund | 1.1% | $12.5M | 1,160,296 | — | Q2 2026 |
| Prospect Capital Advisors, LLCHedge fund | 2.4% | $5.4M | 497,800 | New | Q2 2026 |
| Potomac Capital Management, Inc.Hedge fund | 1.8% | $2.4M | 224,400 | +0.0% shares | Q2 2026 |
| Lion Point Capital, LPHedge fund | 5.8% | $1.2M | 112,434 | +0.0% shares | Q2 2026 |
Each manager counts with its latest 13F (Q2 2026: 7). Screen FENC in the grand portfolio →
FENC stock trades by members of Congress
No member of Congress has disclosed a trade in FENC.
FENC questions and answers
Are insiders buying FENC stock?
Between Aug 1, 2026 and Oct 29, 2026, 4 FENC insiders filed 5 sales worth $1.4M on SEC Form 4, and no open-market purchases; 4 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own FENC?
7 13F filers hold FENC among their 50 largest positions, worth $102.8M combined. The biggest bets by portfolio weight are Rosalind Advisors, Inc. (12.9%), Solas Capital Management, LLC (10.9%) and Lion Point Capital, LP (5.8%). In their latest 13Fs, 1 manager opened a new position and 2 added to one.
Has Congress traded FENC?
No member of Congress has disclosed a trade in FENC.
Who is the largest holder of FENC?
Among 13F filers, Rosalind Advisors, Inc. reports the largest FENC position, $34.3M (3,188,001 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Rosalind Advisors, Inc.'s: 12.9% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.